Puma Biotechnology | PBYI - PE Price to Earnings


Puma Biotechnology reported 13.93 in PE Price to Earnings for its fiscal quarter ending in June of 2024.





Pe Change Date
Agios Pharmaceuticals 3.56 0 Mar/2026
Alnylam Pharmaceuticals 75.64 4.4 Jun/2026
Amgen 18.07 1.77 Jun/2026
Biogen 23.23 9.53 Jun/2026
BioMarin Pharmaceutical 21.07 5.79 Jun/2026
Daiichi Sankyo 20.14 0.6 Jun/2026
Exelixis 18.02 4.11 Jun/2026
Gilead Sciences 13.51 4.2 Jun/2026
Glaxosmithkline 15.09 3.43 Mar/2026
Incyte 14.45 0.9 Jun/2026
Moderna 27.22 14.51 Jun/2023
Novartis 22.41 2.24 Jun/2026
Pfizer 11.48 2.16 Jun/2026
PTC Therapeutics 8.76 1.22 Mar/2026
Puma Biotechnology 13.93 44.88 Jun/2024
Regeneron Pharmaceuticals 15.46 9.68 Jun/2026
Roche Holding 16.48 0.39 Jun/2026
Sarepta Therapeutics 27.27 0 Mar/2026
Takeda 24.4 22.12 Jun/2026
TG Therapeutics 19.64 7.65 Jun/2026
Vanda Pharmaceuticals 16.79 7.07 Jun/2023
Vertex Pharmaceuticals 28.05 2.22 Jun/2026